Dan Polen - Polen Capital Management
Holding/activity history for BridgeBio Pharma, Inc. (BBIO)
← All BBIO superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 45,934 | 0.02 | Add 20.12% | <0.01 | $62.77–84.94 · VW $72.33i | $3,411,059 | SEC |
| 2025 Q4 | 38,241 | 0.01 | Add 5.74% | <0.01 | $52.75–78.54 · VW $65.98i | $2,925,054 | SEC |
| 2025 Q3 | 36,164 | 0.01 | Add 1.44% | <0.01 | $42.09–54.60 · VW $48.93i | $1,878,358 | SEC |
| 2025 Q2 | 35,649 | <0.01 | Buy | <0.01 | $28.33–45.48 · VW $37.40i | $1,539,324 | SEC |
Price snapshot:
Current price$83.08
Avg. buy price$49.99
+/- since buy66.19%
52-week low$42.09
52-week high$93.42